Fri Sep 06 23:59:46 UTC 2024: – The EMA’s safety committee has recommended measures to reduce the risk of agranulocytosis, a side effect of the painkiller metamizole, which can lead to serious infections.
– The PRAC also recommended measures to minimize the risk of meningioma, a type of brain tumor, with medicines containing medroxyprogesterone acetate.
– Dr Liana Martirosyan has been elected as the vice-chair of the PRAC.
– Patients taking high doses of medroxyprogesterone should be monitored for symptoms of meningioma.
– Patients with moderate or severe renal impairment should interpret blood uracil levels for DPD deficiency with caution when taking chemotherapy medicines containing 5-fluorouracil.

Read More